|
Volumn 6, Issue 12, 2005, Pages 1195-1199
|
Comparison of low-molecular-weight-heparin and unfractionated heparin for acute PTE.
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTICOAGULANT AGENT;
DRUG DERIVATIVE;
HEPARIN;
ITF 300;
LOW MOLECULAR WEIGHT HEPARIN;
ARTICLE;
CHINA;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COST BENEFIT ANALYSIS;
DRUG COST;
ECONOMICS;
FEMALE;
HUMAN;
LUNG EMBOLISM;
MALE;
MIDDLE AGED;
PREVALENCE;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
ANTICOAGULANTS;
CHINA;
COST-BENEFIT ANALYSIS;
DRUG COSTS;
FEMALE;
HEPARIN;
HEPARIN, LOW-MOLECULAR-WEIGHT;
HUMANS;
MALE;
MIDDLE AGED;
PREVALENCE;
PROGNOSIS;
PULMONARY EMBOLISM;
TREATMENT OUTCOME;
|
EID: 33644810207
PISSN: 16731581
EISSN: None
Source Type: Journal
DOI: 10.1631/jzus.2005.B1195 Document Type: Article |
Times cited : (7)
|
References (0)
|